Funding news
Pulmonx Corporation logo

Pulmonx Corporation Raises $66.0M

Recently funded · $66.0M Series dHospitals and Health CareUSView source

Get the full Pulmonx Corporation company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Pulmonx Corporation, the company behind a minimally invasive treatment for severe COPD and emphysema, has raised $66.0M in Series d funding.

The company's flagship product, the Zephyr Endobronchial Valve, offers a one-time bronchoscopic procedure. During the treatment, tiny valves are placed in the airways to block off diseased parts of the lung, allowing trapped air to escape and healthier sections to expand. This process helps patients breathe easier and reduces shortness of breath.

Other United States companies recently funded

View all

Biggest recent Healthcare rounds

Largest funding rounds in Healthcare on Signalbase right now.

#CompanyAmount
1
Kismet logo

Kismet

Australia

$42.0B
2
Johnson & Johnson logo

Johnson & Johnson

United States

$7.0B
3
Inari Medical logo

Inari Medical

United States

$4.9B
4
MultiPlan logo

MultiPlan

United States

$4.5B
5
BABYLON HEALTHCARE SERVICES LIMITED logo

BABYLON HEALTHCARE SERVICES LIMITED

United Kingdom

$4.2B

Other recent Series d rounds

Companies that recently closed a Series d round.

#CompanyAmount
1
Lytro (Acquired by Google) logo

Lytro (Acquired by Google)

United States

$60.0M
2
Atlassian logo

Atlassian

Australia

$150.0M
3
Zumper logo

Zumper

United States

$30.0M
4
Newshore (a FLYR company) logo

Newshore (a FLYR company)

Spain

$225.0M
5
TiDB, powered by PingCAP logo

TiDB, powered by PingCAP

United States

$300.0M